ReviewContemporary clinical trials communications2022

The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: A systematic review and network meta-analysis.

Yousef Alhindi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.